Elaris FlexCo Deal History & Licensing Activity
Elaris FlexCo is a life sciences. Over the past three years, Elaris FlexCo has been involved in 1 licensing and acquisition transaction, with a primary focus on Vaccines (2 deals).
Deals (12mo)
1
Active Trials
0
Top Modality
Vaccines
Focus Area
Infectious Disease
Elaris FlexCo Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Elaris FlexCo in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| VLA84 | Valneva SE | Vaccines | Preclinical | license | Mar 2026 |
Elaris FlexCo Pipeline Focus
Therapeutic areas and modalities where Elaris FlexCo is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Elaris FlexCo's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Infectious Disease assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Infectious Disease Deal Benchmarks
Market sizing, deal terms, and competitive landscape for infectious disease
Vaccines Benchmarks
Upfront, milestone, and royalty benchmarks for vaccines deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Elaris FlexCo Licensing & Deal Activity
Elaris FlexCo is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Elaris FlexCo ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Elaris FlexCo include Infectious Disease (2 deals and trials). In terms of modality, Elaris FlexCo has shown particular interest in vaccines.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Elaris FlexCo and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Elaris FlexCo's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.